Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07268612 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this observational study is to evaluate the safety and clinical benefit of two doses of CYFENDUS vaccine when used with the concurrent recommended antibacterial regimen for post-exposure prophylaxis to prevent inhalational anthrax and/or anthrax meningitis.
Trial Details
NCT Number NCT07268612
Lead Sponsor Emergent BioSolutions
Conditions
(from sponsor)		 Anthrax
Related terms Anthrax, Cutaneous anthrax, Gastrointestinal anthrax, Inhalation anthrax
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov